Business Wire - IMPAX Launches Generic Version of Wellbutrin SR 200mg Tablets
December 22, 2004 -- HAYWARD, Calif. -- IMPAX Laboratories, Inc. (Nasdaq:IPXL) today announced that the Company has begun commercial distribution of its Bupropion...
Business Wire - Andrx Relinquishes Exclusivity Rights to 150mg Generic Wellbutrin SR
March 22, 2004 -- Business Editors/Health/Medical Writers FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--March 22, 2004 Andrx Corporation (Nasdaq:ADRX) (
Business Wire - IMPAX Announces Favorable Decision in Wellbutrin SR Patent Appeal
January 29, 2004 -- Business Editors/Health/Medical Writers HAYWARD, Calif.--(BUSINESS WIRE)--Jan. 29, 2004 IMPAX Laboratories, Inc. (NASDAQ:IPXL) announced that the...
Business Wire - Andrx Signs Agreement with Impax and Teva for Generic Formulations of Wellbutrin SR and Zyban
July 31, 2003 -- Business Editors/Health/Medical Writers FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--July 31, 2003 Andrx Corporation (Nasdaq:ADRX) (
Business Wire - IMPAX Signs Agreement with Andrx and Teva for Generic Formulations of Wellbutrin SR and Zyban
July 31, 2003 -- Business Editors/Health/Medical Writers HAYWARD, Calif.--(BUSINESS WIRE)--July 31, 2003 IMPAX Laboratories, Inc. (NASDAQ:IPXL) announced today...
Business Wire - Teva Signs Agreement with Andrx and IMPAX for Generic Formulations of Wellbutrin SR and Zyban
July 31, 2003 -- Business Editors/Health/Medical Writers JERUSALEM--(BUSINESS WIRE)--July 31, 2003 Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA) announced...
Business Wire - IMPAX Receives Final FDA Approval for Generic Version of Wellbutrin SR 150 MG
March 22, 2004 -- Business Editors/Health/Medical Writers HAYWARD, Calif.--(BUSINESS WIRE)--March 22, 2004 IMPAX Laboratories, Inc. (Nasdaq:IPXL) today announced...
Business Wire - IMPAX Receives FDA Approval for Generic Versions of Wellbutrin SR; Final Approval Issued for the 100 mg Strength
January 28, 2004 -- Business Editors/Health/Medical Writers HAYWARD, Calif.--(BUSINESS WIRE)--Jan. 28, 2004 IMPAX Laboratories, Inc. (NASDAQ:IPXL) announced that the...
Business Wire - Andrx Granted Temporary Restraining Order Regarding Generic Wellbutrin SR 100 mg Tablets
December 3, 2003 -- Business Editors/Health & Medical Writers FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Dec. 3, 2003 Andrx Corporation (Nasdaq:ADRX) announced that...
Business Wire - Andrx Comments on Court of Appeals Decision on its Wellbutrin SR/Zyban ANDAs
September 23, 2003 -- Business Editors/Legal, Health & Medical Writers FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Sept. 23, 2003 Andrx Corporation (Nasdaq:ADRX)...
